Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Endocor is a private German medical device company focused on coronary and peripheral interventional products for cardiovascular and endovascular disease. The company develops, manufactures, and markets PCI and endovascular devices including drug-eluting balloons, drug-eluting stents, peripheral stents, guide wires, thrombectomy catheters, interventional kits, and accessories. Its marketed portfolio includes products such as the SEQUENCE sirolimus-eluting coronary stent and the AVANT/AVANT PLUS paclitaxel-eluting balloon platforms, alongside guide wires and closure/accessory products. Endocor also operates a physician training and collaboration service division, IEEN, to support endovascular education and product adoption. The business appears to be commercially active and export-oriented, with distributor outreach spanning Europe, Asia, the Middle East, and South America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Endocor.